- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
North Chicago Today
By the People, for the People
Westfield Capital Management Co. LP Buys $1.84M Stake in AbbVie Inc.
Hedge fund takes new position in pharmaceutical company AbbVie.
Mar. 3, 2026 at 7:39am
Got story updates? Submit your updates here. ›
Westfield Capital Management Co. LP, a hedge fund, bought a new position in shares of AbbVie Inc. (NYSE:ABBV) during the third quarter, according to the company's recent 13F filing with the Securities and Exchange Commission. The firm purchased 7,928 shares of the company's stock, valued at approximately $1,836,000.
Why it matters
This investment by Westfield Capital Management Co. LP in AbbVie highlights the continued interest from institutional investors in the pharmaceutical company. AbbVie is a major player in the biopharmaceutical industry, known for its immunology, oncology, and other specialty drug products.
The details
According to the 13F filing, Westfield Capital Management Co. LP purchased 7,928 shares of AbbVie stock during the third quarter. This new position is valued at approximately $1.84 million. The filing also shows that other hedge funds have been active in trading AbbVie shares, with Vanguard Group Inc. and Raymond James Financial Inc. among the largest institutional holders of the stock.
- Westfield Capital Management Co. LP bought the AbbVie shares during the third quarter of 2026.
The players
Westfield Capital Management Co. LP
A hedge fund that manages investments in various sectors, including the pharmaceutical industry.
AbbVie Inc.
A global biopharmaceutical company that focuses on developing and commercializing therapies for complex and chronic medical conditions.
The takeaway
This investment by Westfield Capital Management Co. LP in AbbVie reflects the continued institutional interest in the pharmaceutical company and its portfolio of specialty drug products. As AbbVie continues to navigate the competitive biopharmaceutical landscape, its ability to attract investment from major hedge funds will be an important factor in its long-term success.
